Although BGJ398 enhanced the anti-tumor effect of PTX, it is unclear whether the synergistic effect of PTX and BGJ398 is mainly derived from the inhibition of FGFR1 or its other target molecules. The gene discussed is FGFR1; the disease is neoplasm.